retinoic acid receptor beta
Showing 1 - 25 of >10,000
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Atezolizumab
- Tretinoin
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 27, 2022
High-risk Neuroblastoma Trial in China (Dinutuximab Beta, 13 cis retinoic acid)
Active, not recruiting
- High-risk Neuroblastoma
- Dinutuximab Beta
- 13 cis retinoic acid
-
Beijing, Beijing, China
- +3 more
Dec 7, 2022
Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)
Recruiting
- Type 2 Diabetes
- Obesity
- Formoterol Fumarate 12 micrograms Inhalation Powder
- +8 more
-
Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
Sep 22, 2022
Fibrodysplasia Ossificans Progressiva Trial in Paris (Palovarotene)
Completed
- Fibrodysplasia Ossificans Progressiva
-
Paris, FranceHôpital Necker-Enfants Malades, Department of Genetics
Jul 28, 2022
Novel Immune Modulating Dietary Supplement on House Dust Mite
Completed
- Dust Mite Allergy
- Allergic Rhinitis
- holo-BLG (beta-lactoglobulin) - a major component of the protein fraction of raw milk, is loaded with ligands such as retinoic acid, zinc and polyphenol-iron complexes.
-
Berlin, GermanyECARF Institute GmbH
Apr 23, 2021
Scalp Psoriasis Trial in Karachi (Tazarotene 0.045% Topical Application Lotion [ARAZLO])
Completed
- Scalp Psoriasis
- Tazarotene 0.045% Topical Application Lotion [ARAZLO]
-
Karachi, Sindh, PakistanJPMC
Aug 28, 2023
Male Infertility, Klinefelter's Syndrome, Y-chromosome Microdeletions Trial in Seattle (13-cis retinoic acid, Calcitriol)
Completed
- Male Infertility
- +2 more
- 13-cis retinoic acid
- Calcitriol
-
Seattle, WashingtonUniversity of Washington Medical Center
Jul 29, 2021
Melanoma Trial in Aurora (VESANOID, Ipilimumab)
Active, not recruiting
- Melanoma
-
Aurora, ColoradoUniversity of Colorado Hospital
Sep 7, 2022
Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)
Recruiting
- Acute Promyelocytic Leukemia
- +2 more
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Apr 26, 2023
Conditions Influencing Health Status, Healthy, Prostate Cancer Trial in United States (laboratory biomarker analysis,
Active, not recruiting
- Conditions Influencing Health Status
- +2 more
- laboratory biomarker analysis
- transrectal prostate biopsy
-
Arcadia, California
- +4 more
Mar 17, 2022
MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)
Recruiting
- Myelodysplastic Syndromes
- Tamibarotene + Azacitidine
- Tamibarotene Matched Placebo + Azacitidine
-
Tucson, Arizona
- +87 more
Feb 2, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- SY-1425 (tamibarotene)
- +2 more
-
Hartford, Connecticut
- +25 more
May 4, 2022
Post COVID-19 Anosmia (Loss of Smell) Trial in Foshan, Kafr Ash Shaykh, Riyadh (Aerosolized 13 cis retinoic acid plus Vitamin D,
Not yet recruiting
- Post COVID-19 Anosmia (Loss of Smell)
- Aerosolized 13 cis retinoic acid plus Vitamin D
- +2 more
-
Foshan, Guangdong, China
- +2 more
Nov 9, 2021
Obesity, Inflammation Trial in Madison (Yogurt, Control food)
Completed
- Obesity
- Inflammation
- Yogurt
- Control food
-
Madison, WisconsinDepartment of Food Science, Babcock Hall
Nov 15, 2022
Male Infertility, Azoospermia Trial in Seattle (13-cis retinoic acid)
Completed
- Male Infertility, Azoospermia
- 13-cis retinoic acid
-
Seattle, WashingtonUniversity of Washington Medical Center
Sep 27, 2021
Acne Vulgaris Trial in Dripping Springs, Pflugerville (Isotretinoin, Amzeeq 4% Topical Foam)
Active, not recruiting
- Acne Vulgaris
- Isotretinoin
- Amzeeq 4% Topical Foam
-
Dripping Springs, Texas
- +1 more
Mar 22, 2022
COVID19 Trial in Cairo (Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment, Isotretinoin(Aerosolized 13 cis
Not yet recruiting
- COVID19
- Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
- +4 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Jul 29, 2021
Covid19 Vaccine Trial (drug, combination product, biological)
Not yet recruiting
- Covid19 Vaccine
- Oral 13 cis retinoic acid
- +4 more
- (no location specified)
May 28, 2021
Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic
Not yet recruiting
- Tuberculosis
- 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
- +5 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Oct 11, 2021
Allergy to Cats, Allergic Rhinoconjunctivitis Trial in Berlin (holoBLG)
Completed
- Allergy to Cats
- Allergic Rhinoconjunctivitis
- holoBLG
-
Berlin, GermanyECARF Institute GmbH
Jul 8, 2022
Type I Diabetes Trial in Birmingham (Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active
Completed
- Type I Diabetes
- Placebo GABA and Placebo GAD-alum
- +2 more
-
Birmingham, AlabamaChildren's of Alabama
May 2, 2022
MDS Trial (Roxadustat in combination with retinoic acid)
Not yet recruiting
- Myelodysplastic Syndromes
- Roxadustat in combination with retinoic acid
- (no location specified)
Aug 26, 2023
ALDH1A1 Expression in Invasive Mammary Carcinoma
Enrolling by invitation
- Breast Cancer
-
Sohag, EgyptFaculty of Medicine
Nov 12, 2023
Multiple Myeloma Trial in Amsterdam (all-trans retinoic acid (ATRA))
Active, not recruiting
- Multiple Myeloma
- all-trans retinoic acid (ATRA)
-
Amsterdam, NH, NetherlandsVU University Medical Center
May 5, 2022
Serum Retinoic Acid Induced Protein 14 and Metastasis Associated
Not yet recruiting
- Breast Cancer
- laboratory test (RAI14 and MACC-1 )
- (no location specified)
Oct 18, 2023